...
首页> 外文期刊>Materials science & engineering >A new bi-layered scaffold for osteochondral tissue regeneration: In vitro and in vivo preclinical investigations
【24h】

A new bi-layered scaffold for osteochondral tissue regeneration: In vitro and in vivo preclinical investigations

机译:一种用于骨软骨组织再生的新型双层支架:体外和体内临床前研究

获取原文
获取原文并翻译 | 示例
           

摘要

Current treatments for acute or degenerative chondral and osteochondral lesions are in need of improvement, as these types of injuries lead to disability and worsen the quality of life in a high percentage of patients. The aim of this study was to develop a new bi-layered scaffold for osteochondral tissue regeneration through a "biomimetic" and "bioinspired" approach. For chondral regeneration, the scaffold was realized with an organic compound (type I collagen), while for the regeneration of the subchondral layer, bioactive magnesium-doped hydroxyapatite (Mg/HA) crystals were co-precipitated with the organic component of the scaffold. The entire scaffold structure was stabilized with a cross-linking agent highly reactive bis-epoxyde (1,4-butanediol diglycidyl ether - BDDGE 1 wt%). The developed scaffold was then characterized for its physico-chemical characteristics. Its structure and adhesion strength between the integrated layers were investigated. At the same time, in vitro cell culture studies were carried out to examine the ability of chondral and bone scaffold layers to separately support adhesion, proliferation and differentiation of human mesenchymai stem cells (hMSCs) into chondrocytes and osteoblasts, respectively. Moreover, an in vivo study with nude mice, transplanted with osteochondral scaffolds plain or engineered with undifferentiated hMSCs, was also set up with 4 and 8-week time points. The results showed that chondral and bone scaffold layers represented biocompatible scaffolds able to sustain hMSCs attachment and proliferation. Moreover, the association of scaffold stimuli and differentiation medium, induced hMSCs chondrogenic and osteogenic differentiation and deposition of extracellular matrix (ECM). The ectopic implantation of the engineered osteochondral scaffolds indicated that hMSCs were able to colonize the osteochondral scaffold in depth. The scaffold appeared permissive to tissue growth and penetration, ensuring the diffusion of nutrients and oxygen, as also suggested by the presence of a neo-angiogenesis process, especially at 4 weeks. Moreover, the in vivo results further confirmed the great potential of the scaffold in tissue engineering, as it was able to support the initial formation of new bone and chondral tissue, confirming the importance of combined and innovative strategies to improve the available therapeutic strategies for chondral and osteochondral regeneration.
机译:目前急需治疗急性或退行性软骨和骨软骨病变的方法,因为这些类型的伤害会导致残疾,并使高比例患者的生活质量恶化。这项研究的目的是通过“仿生”和“仿生”方法开发一种新型的双层软骨支架组织再生支架。对于软骨再生,用有机化合物(I型胶原)实现支架,而对于软骨下层的再生,将生物活性掺杂镁的羟基磷灰石(Mg / HA)晶体与支架的有机成分共沉淀。整个支架结构用交联剂高反应性双环氧化合物(1,4-丁二醇二缩水甘油醚-BDDGE 1 wt%)稳定。然后根据其物理化学特征对已开发的支架进行表征。研究了其结构和集成层之间的粘合强度。同时,进行了体外细胞培养研究,以检查软骨和骨支架层分别支持人间充质干细胞(hMSCs)分别粘附于软骨细胞和成骨细胞的能力,增殖和分化能力。此外,还建立了一个裸鼠的体内研究,该裸鼠移植了普通的骨软骨支架或用未分化的hMSC进行了工程改造,时间分别为4周和8周。结果表明,软骨和骨支架层代表了能够维持hMSCs附着和增殖的生物相容性支架。此外,支架刺激物与分化培养基的结合,诱导了hMSCs的成软骨和成骨分化以及细胞外基质(ECM)的沉积。工程骨软骨支架的异位植入表明hMSCs能够在骨软骨支架中深入定植。支架似乎允许组织生长和穿透,从而确保营养物质和氧气的扩散,新血管生成过程的存在也证明了这一点,尤其是在第4周。此外,体内结果进一步证实了支架在组织工程中的巨大潜力,因为它能够支持新的骨骼和软骨组织的初步形成,从而证实了结合和创新策略对改善软骨可用治疗策略的重要性。和骨软骨再生。

著录项

  • 来源
    《Materials science & engineering》 |2017年第1期|101-111|共11页
  • 作者单位

    Laboratory of Biocompatibility, Technological Innovations and Advanced Therapies, Rizzoli Orthopedic Institute, Bologna, Italy;

    Laboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Via Di Barbiano, 1/10,40136 Bologna, - Italy;

    Laboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Bologna, Italy,Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy;

    Innovative Technology Platform for Tissue Engineering, Theranostic and Oncology, Rizzoli Orthopedic Institute, Palermo, Italy;

    Innovative Technology Platform for Tissue Engineering, Theranostic and Oncology, Rizzoli Orthopedic Institute, Palermo, Italy;

    Fin-Ceramica Faenza SpA, Faenza, Ravenna, Italy;

    Laboratory of Musculoskeletal Cell Biology, Rizzoli Orthopedic Institute, Bologna, Italy;

    Laboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Bologna, Italy;

    Laboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Bologna, Italy;

    Innovative Technology Platform for Tissue Engineering, Theranostic and Oncology, Rizzoli Orthopedic Institute, Palermo, Italy;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Osteochondral lesion; Biomimetic; Bi-layered scaffold; Collagen Ⅰ; Magnesium-doped hydroxyapatite; Molecular biology; Animal model; Implant; Histology;

    机译:骨软骨病变;仿生;双层支架;Ⅰ型胶原镁掺杂羟基磷灰石;分子生物学;动物模型注入;组织学;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号